OTC Pharmaceuticals in Brazil

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Report
Pages	35
ISBN Number	not applicable
Product Code	DAT02658

Price

£125.00
approximately: $221 | €159

PDF

Order above formats by FAX

Summary

Datamonitor's OTC Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by both value and volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer and/or brand
Also features market breakdown by distribution channel

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange v the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Content

Executive Summary
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
Chapter 3 Market Segmentation I
Chapter 4 Market Segmentation Ii
Chapter 5 Market Share
Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
Chapter 7 Leading Companies
- 7.1 Pfizer Inc
- 7.2 Glaxosmithkline Plc
- 7.3 Novartis Ag
Chapter 8 Distribution
Chapter 9 Market Forecasts
- 9.1 Market Value Forecast
Chapter 10 Macroeconomic Indicators
Chapter 11 Appendix
- 11.1 Methodology
- 11.2 Industry Associations
- 11.3 Related Datamonitor Research
List Of Tables
- Table 1: Brazil Otc Pharmaceuticals Market Value: $ Billion, 2003-2007
- Table 2: Brazil Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Brazil Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Brazil Otc Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Pfizer Inc
- Table 6: Key Financials: Pfizer Inc
- Table 7: Key Facts: Glaxosmithkline Plc
- Table 8: Key Financials: Glaxosmithkline Plc
- Table 9: Key Facts: Novartis Ag
- Table 10: Key Financials: Novartis Ag
- Table 11: Brazil Otc Pharmaceuticals Distribution: % Share, By Value, 2007
- Table 12: Brazil Otc Pharmaceuticals Market Value Forecast: $ Billion, 2007-2012
- Table 13: Brazil Size Of Population (Million) , 2003-2007
- Table 14: Brazil Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 15: Brazil Inflation, 2003-2007
- Table 16: Brazil Exchange Rate, 2003